Abstract
A generation of children is at risk after missing out on school, essential vaccinations as well as food crisis and loss of parents from COVID-19. The impact of COVID-19 in Low-and-middle income countries is immense and the estimated losses will take years to recover and or permanently affect some of the struggling economies. According to the WHO World Malaria Report 2021, moderate disruptions were observed in malaria endemic countries, despite a 17% increase in malaria cases globally and two thirds of mortality cases in 2020 attributing to COVID-19 related disruptions. According to the 2021 UNAIDS report, eight countries were able to reach the 90-90-90 target while 19 countries managed to reach at least one of the targets. COVID-19 negatively affected identification of new TB cases, treatment and follow up of existing cases, as well as control and prevention of spread of TB within affected communities. The reporting of TB cases by countries was also affected with shortfalls in reporting observed in different regions of the world including India (41%), Philippines (12%), China (8%), Indonesia (14%). This chapter systematically analyses three communicable disease priorities, Malaria, TB and HIV, its targets and indicators and how these have been affected by the COVID-19 pandemic. Despite strides being made in some areas SDG3.3, the COVID-19 pandemic has caused interruptions that have and will considerably affect vaccination coverage as well as the progress that was made. The overarching question remains, can LMIC be able to build sustainable health systems?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adewole OO (2020) Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria. Int J Tuberc Lung Dis 24(9):981–982. https://doi.org/10.5588/IJTLD.20.0418
Alagna R, Bessozi G, Codesca LR, Gori A, Migliori GB, Raviglione M, Cirillo DM (2020) Celebrating World Tuberculosis Day at the time of COVID-19. Eur Respir J 55:2000650. https://doi.org/10.1183/13993003.00650-2020
Anthony R (2012) The CIA’ s vaccination ruse. J Public Health Policy 33(August):387–389. https://doi.org/10.1057/jphp.2012.37
Arce JSS, Warren SS, Meriggi NF, Scacco A, Mcmurry N, Voors M et al (2021) COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med 27:1385–1394. https://doi.org/10.1038/s41591-021-01454-y
Battista Migliori G, Min Thong P, Akkerman O, Alffenaar J-W, Álvarez-Navascués F, Mohamed Assao-Neino M et al (2020) Emerging infectious diseases WWW worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020 the Philippines (M. Calnan). Barts Health National Health Service Trust 26(11):2709–2712. https://doi.org/10.3201/eid2611.203163
Blair RA, Morse BS, Tsai LL (2017) Social science & medicine public health and public trust: survey evidence from the Ebola virus disease epidemic in Liberia. Soc Sci Med 172:89–97. https://doi.org/10.1016/j.socscimed.2016.11.016
Buonsenso D, Iodice F, Sorba Biala J, Goletti D (2021) COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology 27(1):67. https://doi.org/10.1016/J.PULMOE.2020.05.013
Chaccour J (2018) Authorship trends in The Lancet Global Health: only the tip of the iceberg? Lancet Glob Health 6(5):e497. https://doi.org/10.1016/S2214-109X(18)30110-4
Choi JY (2020) The HIV Care Cascade in Korea: status of UNAIDS 90-90-90 targets. https://doi.org/10.3346/jkms.2020.35.e55
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N et al (2016) Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 375(9):830. https://doi.org/10.1056/NEJMOA1600693
Eisinger RW, Fauci AS (2018) Ending the HIV/AIDS Pandemic. Emerg Infect Dis 24(3):413. https://doi.org/10.3201/EID2403.171797
Ellman T (2015) Demedicalizing AIDS prevention and treatment in Africa. N Engl J Med 372(4):303–305. https://doi.org/10.1056/NEJMp1414213
Fauci AS, Marston HD (2015) Ending the HIV–AIDS pandemic — follow the science. N Engl J Med 373(23):2197–2199. https://doi.org/10.1056/NEJMP1502020/SUPPL_FILE/NEJMP1502020_DISCLOSURES.PDF
Global Polio Eradication Initiative (2020) UNICEF and WHO call for emergency action to avert major measles and polio epidemics. World Health Organization. https://www.who.int/news/item/06-11-2020-unicef-and-who-call-for-emergency-action-to-avert-major-measles-and-polio-epidemics. Accessed 26 Mar 2023
Ho LL, Gurung S, Mirza I, Nicolas HD, Steulet C, Burman AL et al (2022) Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns. Int J Infect Dis 119:201–209. https://doi.org/10.1016/j.ijid.2022.04.005
Jegede AS (2007) What Led to the Nigerian Boycott of the Polio Vaccination Campaign? 4(3):e73. https://doi.org/10.1371/journal.pmed.0040073
Joint United Nations Programme on HIV/AIDS. (2022) UNAIDS Global AIDS Update 2022. UNAIDS Global AIDS Update 2022, 2022, 1–22
Joint United Nations Programme ON HIV/AIDS (UNAIDS). (n.d.). Joint United Nations Programme ON HIV/AIDS (UNAIDS) 90-90-90 An ambitious treatment target to help end the AIDS epidemic [Online] UNAIDS, Geneva (2014). http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf
Jones HS, Floyd S, Stangl A, Bond V, Hoddinott G, Pliakas T et al (2020) Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa. Trop Med Int Health 25(10):1246–1260. https://doi.org/10.1111/tmi.13473
Kelaher M, Ng L, Knight K, Rahadi A (2016) Equity in global health research in the new millennium: trends in first-authorship for randomized controlled trials among low- and middle-income country researchers 1990-2013. Int J Epidemiol 45(6):2174–2183. https://doi.org/10.1093/ije/dyw313
Khopkar-Kale P, Kulkarni S (2021) HIV-2: still off the radar for India’s 90-90-90 targets. Indian J Med Res 154(1):24. https://doi.org/10.4103/IJMR.IJMR_828_19
Klinton JS, Heitkamp P, Rashid A, Faleye BO, Win Htat H, Hussain H et al (2021) One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countries. J Clin Tuberc Other Mycobact Dis 25:100277. https://doi.org/10.1016/j.jctube.2021.100277
Marcus JL, Hurley LB, Nguyen DP, Silverberg MJ, Volk JE (2017) Redefining Human Immunodeficiency Virus (HIV) preexposure prophylaxis failures. Clin Infect Dis 65(10):1768. https://doi.org/10.1093/CID/CIX593
Marinda E, Simbayi L, Zuma K, Zungu N, Moyo S, Kondlo L et al (2020) Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey. BMC Public Health 20:1375. https://doi.org/10.1186/s12889-020-09457-z
Martinez-Bravo M, Stegmann A (2022) In vaccines we trust? The effects of the CIA’s vaccine ruse on immunization in Pakistan. J Eur Econ Assoc 20(1):150–186. https://doi.org/10.1093/jeea/jvab018
Mehta S (2022) Covid-19 update: omicron variant − a new emerging threat. Rocz Panstw Zakl Hig 73(1):13–16. https://doi.org/10.32394/rpzh.2022.0198
Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F et al (2021) Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J 58(5):2101786. https://doi.org/10.1183/13993003.01786-2021
Nkengasong J, Djoudalbaye B, Maiyegun O (2017) A new public health order for Africa’s health security. Lancet Glob Health 5:e1064–e1065. https://doi.org/10.1016/S2214-109X(17)30363-7
Ntata, P. R. T. (2007). Equity in access to ARV drugs in Malawi. SAHARA J …, 4(1), 564–574. doi:https://doi.org/10.1080/17290376.2007.9724818
Pillay Y, Pienaar S, Barron P, Zondi T (2021) Impact of COVID-19 on routine primary healthcare services in South Africa. S Afr Med J 111(8):714–719. https://doi.org/10.7196/SAMJ.2021.V111I8.15786
Pingray V, Ortega V, Yaya S, Belizán JM (2020) Authorship in studies conducted in low-and-middle income countries and published by reproductive health: advancing equitable global health research collaborations. Reprod Health 17(1):18. https://doi.org/10.1186/s12978-020-0858-7
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Van Lunzen J et al (2016) Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 316(2):171–181. https://doi.org/10.1001/JAMA.2016.5148
Sbarra AN, Rolfe S, Nguyen JQ, Earl L, Galles NC, Marks A et al (2021) Mapping routine measles vaccination in low- and middle-income countries. Nature 589(7842):415–419. https://doi.org/10.1038/s41586-020-03043-4
Schermerhorn J, Case A, Graeden E, Kerr J, Moore M, Robinson-Marshall S et al (2022) Fifteen days in December: capture and analysis of Omicron-related travel restrictions. BMJ Glob Health 7(3):e008642. https://doi.org/10.1136/bmjgh-2022-008642
Shet A, Carr K, Danovaro-Holliday MC, Sodha SV, Prosperi C, Wunderlich J et al (2022) Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health 10(2):e186–e194. https://doi.org/10.1016/S2214-109X(21)00512-X
Sinclair JR (2019) Importance of a One Health approach in advancing global health security and the Sustainable Development Goals. Revue Sci Tech (International Office of Epizootics) 38(1):145–154. https://doi.org/10.20506/RST.38.1.2949
Souza M d R, Paz WS d, Sales VB d S, Jesus GFH d, Tavares D d S, Lima SVMA et al (2022) Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk? Front Pharmacol 13(June):1–10. https://doi.org/10.3389/fphar.2022.891711
Trajman A, Felker I, Alves LC, Coutinho I, Osman M, Meehan SA et al (2022) The COVID-19 and TB syndemic: the way forward. Int J Tuber Lung Dis 26(8):710–719. https://doi.org/10.5588/ijtld.22.0006
Troiano G, Nardi A (2020) Vaccine hesitancy in the era of COVID-19. (January)
UN Joint Programme on HIV/AIDS (UNAIDS). (2021) Global AIDS updates confronting inequities. 386
UNAIDS. (2016) 2016 United Nations political declaration on ending AIDS sets world on the fast-track to end the epidemic by 2030. http://www.unaids.org/sites/default/files/20160608_PS_HLM_Political_Declaration_final.pdf
UNAIDS. (n.d.) UNAIDS global AIDS update 2022
UNICEF. (2021) Lessons learned and good practices: country-specific case studies on immunization activities during the COVID-19 pandemic. https://www.unicef.org/documents/lessons-learned-and-good-practices-country-specific-case-studies-immunization-activities
United Nations (2021) Goal 3|Department of Economic and Social Affairs [Online]. UN Online. https://SDG.un.org/goals/goal3. Accessed 17 Mar 2023
Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ et al (2018) A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis 18(4):431–440. https://doi.org/10.1016/S1473-3099(18)30004-5
Wang X, Zhang X, He J (2020) Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China. Biosci Trends 14(1):3–8. https://doi.org/10.5582/bst.2020.01043
WHO (2022) The mRNA vaccine technology transfer hub. World Health Organisation. https://www.who.int/initiatives/the-mrna-vaccine-technology-transfer-hub. Accessed 17 Mar 2023
World Health Organisation(WHO) Geneva. (2021a) Global Tuberculosis Report 2021. In News. Geneva
World Health Organisation(WHO) Geneva. (2021b) World Malaria Report 2021. Geneva
World Health Organisation(WHO) Geneva. (n.d.) GIN June 2020. https://www.who.int/publications/m/item/gin-june-2020. Accessed 16 Mar 2023
World Health Organization (2015) The End Strategy TB. End TB Strategy 53(9):1689–1699
World Health Organization. (2020a) Global Tuberculosis Report 2020. https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
World Health Organization. (2020b) Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020. In Interim report. COVID-19. Essential Health Services. https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1
Wouters OJ, Shadlen KC, Salcher-konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M (2021) Health Policy Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 397(10278):1023–1034. https://doi.org/10.1016/S0140-6736(21)00306-8
Wu Z, Chen J, Xia Z, Pan Q, Yuan Z, Zhang W, Shen X (2020) Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China. Int J Tuberc Lung Dis 24(10):1122–1124. https://doi.org/10.5588/IJTLD.20.0539
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mphande, F.A. (2023). Sustainable Health in Low and Middle Income Countries; Focus on SDG Target 3.3, 3b, 3c and 3d. In: Sustainable Health in Low and Middle Income Countries. Sustainable Development Goals Series. Springer, Singapore. https://doi.org/10.1007/978-981-99-4254-1_1
Download citation
DOI: https://doi.org/10.1007/978-981-99-4254-1_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-4253-4
Online ISBN: 978-981-99-4254-1
eBook Packages: Social SciencesSocial Sciences (R0)